Reslizumab in gastroenterology: Experience in a patient with eosinophilic gastroenteritis

Gastroenterol Hepatol. 2022 Apr:45 Suppl 1:147-148. doi: 10.1016/j.gastrohep.2021.11.002. Epub 2021 Nov 10.

[Article in English, Spanish]

Authors

Alejandro García Martínez¹, Lidia Campos Gonzaga², Daniel Mateos Millán², Juan Antonio Hernani Álvarez², María José Blanco Rodríguez²

Affiliations

¹ Unidad de Gestión Clínica de Enfermedades Digestivas, Hospital Universitario de Jerez de la Frontera, Jerez de la Frontera, Cádiz, España. Electronic address: alegama91@hotmail.com.
² Unidad de Gestión Clínica de Enfermedades Digestivas, Hospital Universitario de Jerez de la Frontera, Jerez de la Frontera, Cádiz, España.

PMID: 34774706
DOI: 10.1016/j.gastrohep.2021.11.002

No abstract available

Publication types

Case Reports

MeSH terms

Anti-Asthmatic Agents*
Antibodies, Monoclonal, Humanized / therapeutic use
Enteritis
Eosinophilia* / complications
Eosinophilia* / drug therapy
Gastritis
Gastroenterology*
Humans

Substances

Anti-Asthmatic Agents
Antibodies, Monoclonal, Humanized
reslizumab

Supplementary concepts

Eosinophilic enteropathy